Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth

Although cisplatin has been shown to be an integral part of chemotherapy regimen in osteosarcoma (OS) treatment, toxicity issues and chemoresistance have hindered therapeutic development for OS. Exploring novel combination therapy methods is needed to circumvent the limitations of cisplatin alone. T...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Res
Hlavní autoři: Sun, Farui, Zhang, Yuanjin, Xu, Lijun, Li, Songbai, Chen, Xiang, Zhang, Ling, Wu, Yifan, Li, Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: Cognizant Communication Corporation 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7844646/
https://ncbi.nlm.nih.gov/pubmed/29191257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504017X15119525209765
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky